Hussman Strategic Advisors, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History

Hussman Strategic Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$43.82 - $85.37 $1.12 Million - $2.18 Million	-25,500 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$33.21 - $51.27 $1.2 Million - $1.85 Million	-36,000 Reduced 58.54%	25,500 $1.1 Million
Q2 2020 Jul 31, 2020	SELL	$26.12 - $43.27 $13,060 - $21,635	-500 Reduced 0.81%	61,500 $2.66 Million
Q1 2020 May 01, 2020	BUY	$20.56 - $63.12 $1.27 Million - $3.91 Million	62,000 New	62,000 $1.78 Million
Q1 2019 May 01, 2019	SELL	$12.05 - $20.18 $602,500 - $1.01 Million	-50,000 Closed	0 $0

Q4 2018 Feb 01, 2019	BUY	$10.74 - $19.7 $537,000 - $985,000	50,000 New	50,000 $621,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.